Here, we describe the epidemiology of RSV, the RSV virion structure, key neutralizing epitopes on the pre- and post-fusion forms of the fusion protein and implications for vaccine development.

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Respiratory syncytial virus was linked to elevated incidence of cardiovascular events in older adults. Future research will help decide whether vaccination could reduce the impact of RSV on the heart.

RSV typically causes cold-like symptoms, but is also a leading cause of pneumonia in toddlers and older adults. An estimated 15,000-20,000 annual RSV-associated hospitalizations occur in the U.S ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.

GSK’s Chief Scientific Officer Tony Wood said in a release that the new guidance would increase the RSV vaccine-eligible patient population by 13 million. Other ACIP vaccine guidance ...

CDC estimates 15K–20K RSV hospitalizations yearly among U.S. adults aged 50–59. RSV causes 42K hospitalizations annually in adults aged 50–64, per U.S. study. China’s new tariffs just ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...